Conditions: Seasonal Allergic Rhinitis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 429
Healthy volunteers: no

Brief summary:
This study is designed to assess the effectiveness of mometasone furoate nasal spray (MFNS) once daily compared with placebo in subjects with seasonal allergic rhinitis (SAR) in reducing the total symptom score.

Detailed description:

Arms:
arm 1: 200 mcg daily arm 2: Two sprays in each nostril in the morning

Interventions: intervention 1: Mometasone furoate nasal spray intervention 2: Placebo
Intervention descriptions: intervention 1: Two sprays (50 mcg/spray) in each nostril (200 mcg daily) in the morning intervention 2: Two sprays in each nostril in the morning

Protocol document: